The FDA is cracking down on a generic drugmaker that was the subject of a ProPublica investigation last year, citing problems with safety tests that delayed the recall of a faulty medicine linked to deaths in the U.S.
https://www.propublica.org/article/fda-letter-glenmark-pharmaceuticals?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post